NIPT Rhesus
from the 11th week of pregnancy
Goals
- Completely risk-free test for the fetal Rhesus factor
Cost of the examination
€300
The NIPT (non-invasive prenatal test) determines whether there is a risk of a chromosomal abnormality. It analyzes fragments of fetal DNA from the mother's blood. NIPT can detect 99.9% of trisomy 21 cases. Furthermore, the test provides information about the risks of trisomy 18 and 13, and the chromosomal sex can be determined.
From the 11th week of pregnancy, the blood draw for the NIPT (Non-Invasive Prenatal Test) can be performed at any point during the pregnancy. The NIPT is always recommended to be accompanied by an ultrasound examination.
The NIPT Rhesus: Risk-free genetic and rhesus factor analysis via blood test
The Non-Invasive Prenatal Test (NIPT) requires only a simple blood draw, making it a completely risk-free alternative for both mother and child compared to chorionic villus sampling and amniocentesis.
The NIPT involves testing the maternal blood, which contains the baby's DNA. An analysis of these fragments of fetal genetic material is used to determine the risk of a genetic abnormality in the unborn child.
An NIPT variant also offers the option to determine the child's Rhesus factor. This is important for pregnant women who are Rhesus-negative. Previously, they were routinely recommended to receive an immunoglobulin vaccination in the 25th–28th week of pregnancy and after birth. This is because the immune systems of these mothers produce antibodies (known as anti-D immunoglobulins) when they come into contact with the blood of their Rhesus-positive child. If the NIPT test determines that—as is the case in 40 percent of instances—the child's Rhesus factor is negative like the mother's, no vaccination is required.
- The results will be available approx. 14 working days after the examination.
Investigation Timeline
Our prenatal center is equipped with its own laboratory. This makes it possible to carry out examinations entirely in our facility and to inform you of the results very quickly.
Book an appointment
Our prenatal center is equipped with its own laboratory. This allows us to perform all examinations entirely in-house.
Cost of the examination
€300Q&A
The NIPT is currently the best risk-free test for determining the probability of chromosomal disorders. In principle, any pregnant woman can opt for this test. The NIPT is recommended for those with an intermediate risk between 1:300 and 1:1,000 after the Combined Test, or as a primary test in cases of higher background risk.
During NIPT (Non-invasive Prenatal Testing), fetal DNA fragments that can be detected in the maternal blood are analyzed using molecular biological methods. These are detectable from gestational week 10 +0.
There are various non-invasive prenatal tests (NIPTs) that vary in their scope. The recommended NIPT used at the Prenatal Center at the Wien screens for trisomy 21, trisomy 18 and 13, as well as the baby's chromosomal sex. In addition, the child's Rhesus factor, triploidies, cystic fibrosis, and other diseases can be tested with varying detection rates.
The costs for the NIPT (non-invasive prenatal test) depend on the scope of the test. We offer 5 different test packages – please refer to our price list for the corresponding prices.
The NIPT (non-invasive prenatal test) is the most reliable non-invasive test for determining the risk of Down syndrome. The detection rate is over 99% for trisomy 21.